1. Home
  2. ACET vs CMTL Comparison

ACET vs CMTL Comparison

Compare ACET & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$7.70

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

N/A

Current Price

$5.12

Market Cap

162.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
CMTL
Founded
1947
1967
Country
United States
United States
Employees
N/A
1385
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
162.1M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
ACET
CMTL
Price
$7.70
$5.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$65.33
$6.00
AVG Volume (30 Days)
161.1K
225.6K
Earning Date
01-01-0001
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
N/A
N/A
Revenue
N/A
$499,528,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.19
52 Week High
$9.05
$6.21

Technical Indicators

Market Signals
Indicator
ACET
CMTL
Relative Strength Index (RSI) 57.76 44.72
Support Level $7.70 $4.86
Resistance Level $8.46 $6.15
Average True Range (ATR) 0.46 0.35
MACD -0.01 -0.06
Stochastic Oscillator 96.30 23.64

Price Performance

Historical Comparison
ACET
CMTL

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

Share on Social Networks: